Angiomyolipoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Angiomyolipoma

subtype

Identifier: CI-CAN-00004480
Entity page: /cancer/angiomyolipoma ↗
Edges: 13

Neighbours: 2 drugs10 trials
Drawn: 12 of 12 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Angiomyolipoma investigated for …INVESTIGATED_FOR1 of 1
← investigated for	Everolimussmall_molecule	unknown	4	Angiomyolipoma	1	Curated	chembl	graph →
Angiomyolipoma investigated in trials for …INVESTIGATED_IN_TRIALSderived2 of 2
→ investigated in trials for

Angiomyolipoma studied in …STUDIED_INderived10 of 10
→ studied in	NCT05252585Phase 4 · active not recruiting A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Kidney Angiomyolipoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06453642NA · active not recruiting Evaluation of a Simple-Prep Controlled Embolic · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Kidney Angiomyolipoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06683846Phase 2 · recruiting Ivonescimab in the Treatment of Multiple Advanced Tumors · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Kidney Angiomyolipoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05785052unknown Biomarkers of Renal Cancer · condition mapped ONTOLOGY_EXACT · 10 trials mapped (3 active)	—	—	Angiomyolipoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02654340terminated Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Kidney Angiomyolipoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02325505completed Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma · condition mapped ONTOLOGY_EXACT · 10 trials mapped (3 active)	—	—	Angiomyolipoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00126672Phase 2 · completed RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS · condition mapped ONTOLOGY_EXACT · 10 trials mapped (3 active)	—	—	Kidney Angiomyolipoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03525834Phase 4 · completed Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. · condition mapped ALIAS · 10 trials mapped (3 active)	—	—	Kidney Angiomyolipoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03477149NA · completed EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications · condition mapped ONTOLOGY_EXACT · 10 trials mapped (3 active)	—	—	Angiomyolipoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01217125Phase 4 · completed Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis · condition mapped ONTOLOGY_EXACT · 10 trials mapped (3 active)	—	—	Angiomyolipoma	1	Observed	clinicaltrials	graph →